BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25661340)

  • 1. A miR-29c binding site genetic variant in the 3'-untranslated region of LAMTOR3 gene is associated with gastric cancer risk.
    Song P; Wang W; Tao G; Chu H; Wang M; Wu D; Tong N; Gong W; Zhou J; Zhang Z; Wang B; Zhu H; Zhao Q
    Biomed Pharmacother; 2015 Feb; 69():70-5. PubMed ID: 25661340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic variant of miR-148a binding site in the SCRN1 3'-UTR is associated with susceptibility and prognosis of gastric cancer.
    Song P; Zhu H; Zhang D; Chu H; Wu D; Kang M; Wang M; Gong W; Zhou J; Zhang Z; Zhao Q
    Sci Rep; 2014 Nov; 4():7080. PubMed ID: 25399950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.
    Li Y; Nie Y; Cao J; Tu S; Lin Y; Du Y; Li Y
    Mol Carcinog; 2014 Mar; 53(3):219-29. PubMed ID: 23065816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
    Lin Y; Nie Y; Zhao J; Chen X; Ye M; Li Y; Du Y; Cao J; Shen B; Li Y
    Carcinogenesis; 2012 Dec; 33(12):2377-83. PubMed ID: 22971574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A miR-151 binding site polymorphism in the 3'-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma.
    Liu Y; Cai H; Liu J; Fan H; Wang Z; Wang Q; Shao M; Sun X; Diao J; Liu Y; Shi Y; Fan Q
    Biochem Biophys Res Commun; 2013 Mar; 432(4):660-5. PubMed ID: 23416081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The miR-184 binding-site rs8126 T>C polymorphism in TNFAIP2 is associated with risk of gastric cancer.
    Xu Y; Ma H; Yu H; Liu Z; Wang LE; Tan D; Muddasani R; Lu V; Ajani JA; Wang Y; Wei Q
    PLoS One; 2013; 8(5):e64973. PubMed ID: 23724109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rs56288038 (C/G) in 3'UTR of IRF-1 Regulated by MiR-502-5p Promotes Gastric Cancer Development.
    Wang B; Yang H; Shen L; Wang J; Pu W; Chen Z; Shen X; Fu J; Zhuang Z
    Cell Physiol Biochem; 2016; 40(1-2):391-399. PubMed ID: 27866197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between miR-149 Gene rs2292832 Polymorphism and Risk of Gastric Cancer.
    Zhang L; Liu Q; Wang F
    Arch Med Res; 2018 May; 49(4):270-277. PubMed ID: 30274913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset.
    Song F; Zheng H; Liu B; Wei S; Dai H; Zhang L; Calin GA; Hao X; Wei Q; Zhang W; Chen K
    Clin Cancer Res; 2009 Oct; 15(19):6292-300. PubMed ID: 19789321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Functional Variant at the miR-214 Binding Site in the Methylenetetrahydrofolatereductase Gene Alters Susceptibility to Gastric Cancer in a Chinese Han Population.
    Chen Q; Qin R; Fang Y; Li H; Liu Y
    Cell Physiol Biochem; 2015; 36(2):622-30. PubMed ID: 25998065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3'-UTR, influence susceptibility to gastric cancer.
    Arisawa T; Tahara T; Shiroeda H; Matsue Y; Minato T; Nomura T; Yamada H; Hayashi R; Saito T; Matsunaga K; Fukuyama T; Hayashi N; Otsuka T; Fukumura A; Nakamura M; Shibata T
    Hum Immunol; 2012 Jul; 73(7):747-52. PubMed ID: 22537748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD24 genetic variants contribute to overall survival in patients with gastric cancer.
    Jia ZF; Wang LZ; Cao XY; Wang C; Cao DH; Wu X; You LL; Jin MS; Wang YP; Zhou BS; Jiang J
    World J Gastroenterol; 2016 Feb; 22(7):2373-82. PubMed ID: 26900300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma.
    Wang W; Li F; Mao Y; Zhou H; Sun J; Li R; Liu C; Chen W; Hua D; Zhang X
    Hum Genet; 2013 Jun; 132(6):641-8. PubMed ID: 23430453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Genetic Variant Located in
    Wang W; Du M; Li Z; Zhang L; Li Q; Xu Z; Li B; Wang L; Li F; Zhang D; Xu H; Yang L; Gong W; Qiang F; Zhang Z; Xu Z
    Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):822-828. PubMed ID: 29685895
    [No Abstract]   [Full Text] [Related]  

  • 15. Polymorphisms and haplotypes of the miR-148/152 family are associated with the risk and clinicopathological features of gastric cancer in a Northern Chinese population.
    Chen X; Wang G; Lu X; Gao P; Song Y; Sun J; Li A; Xu Y; Xu H; Wang Z
    Mutagenesis; 2014 Nov; 29(6):401-7. PubMed ID: 25261463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development.
    Mesic A; Rogar M; Hudler P; Bilalovic N; Eminovic I; Komel R
    BMC Cancer; 2019 Sep; 19(1):919. PubMed ID: 31521144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Single Nucleotide Polymorphisms of miRNAs and Gastric Cancer: A Scoping Review.
    Pan L; Shi Y; Zhang J; Luo G
    Genet Test Mol Biomarkers; 2022 Oct; 26(10):459-467. PubMed ID: 36251855
    [No Abstract]   [Full Text] [Related]  

  • 18. Associations of Il-1 Family-Related Polymorphisms With Gastric Cancer Risk and the Role of Mir-197 In Il-1f5 Expression.
    Chen X; Xu Y; Cao X; Chen Y; Jiang J; Wang K
    Medicine (Baltimore); 2015 Nov; 94(47):e1982. PubMed ID: 26632693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck.
    Liu Z; Wei S; Ma H; Zhao M; Myers JN; Weber RS; Sturgis EM; Wei Q
    Carcinogenesis; 2011 Nov; 32(11):1668-74. PubMed ID: 21934093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: results from the EPIC-EURGAST study.
    Espinosa-Parrilla Y; Muñoz X; Bonet C; Garcia N; Venceslá A; Yiannakouris N; Naccarati A; Sieri S; Panico S; Huerta JM; Barricarte A; Menéndez V; Sánchez-Cantalejo E; Dorronsoro M; Brennan P; Duarte-Salles T; B As Bueno-de-Mesquita H; Weiderpass E; Lund E; Clavel-Chapelon F; Boutron-Ruault MC; Racine A; Numans ME; Tumino R; Canzian F; Campa D; Sund M; Johansson M; Ohlsson B; Lindkvist B; Overvad K; Tjønneland A; Palli D; Travis RC; Khaw KT; Wareham N; Boeing H; Nesi G; Riboli E; Gonzalez CA; Sala N
    Int J Cancer; 2014 Nov; 135(9):2065-76. PubMed ID: 24643999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.